COVID-19

A flu vaccination might do more than protect against influenza. It might also shield some people from a severe case of COVID-19 — even though the infection is caused by an entirely different virus.

Shark attack numbers have sunk to dramatic lows, likely a side effect of closed beaches and widespread quarantines, according to experts at the University of Florida’s International Shark Attack File.

A look back at the contributions of UF’s Emerging Pathogens Institute to campus-wide COVID-19 research.

Guilt and shame are two prevailing emotions surrounding COVID-19. This guilt stems in part from the fact that anyone could be a potential carrier of the virus.

Patients with a vitamin D deficiency were four times more likely to be COVID-19 positive than those with a sufficient amount of the crucial vitamin.

University of Florida Health researchers are joining an ambitious global effort led by The Rockefeller Foundation to better track the coronavirus and its variants and set up a network of collaborators to stop any nascent pandemic in the future.

Members in UF’s Warren B. Nelms Institute, CISE and ECE are developing an affordable wearable device that indicates appropriate social distancing.

David P. Norton, Ph.D., has spent nearly a decade building a collaborative, leading-edge research environment at the University of Florida. But as the number of coronavirus cases began to swell in Florida this spring, Norton and his leadership colleagues faced a daunting challenge: how to pause — and then restart — research at UF’s 16 colleges in Gainesville and dozens of facilities statewide.

Which global distribution strategy for a hypothetical COVID-19 vaccine will save the most lives?

A team of researchers at the University of Florida are using mathematical models to evaluate the impact of current and future COVID-19 interventions.

The race to defeat the novel coronavirus took a major leap forward last week when the Food and Drug Administration and the Centers for Disease Control and Prevention authorized the use of the Pfizer COVID-19 vaccine in children 12 to 15 years old.